Financial News
Articles published by Pyxis Oncology
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201
December 19, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
November 20, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
November 12, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
August 14, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
From Pyxis Oncology
Via GlobeNewswire
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
May 30, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
May 14, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
March 21, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
March 13, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
March 05, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Announces $50 Million Private Placement
February 27, 2024
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
November 28, 2023
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
September 27, 2023
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Successfully Completes Acquisition of Apexigen
August 23, 2023
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update
August 11, 2023
From Pyxis Oncology
Via GlobeNewswire
Tickers
PYXS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.